prana certainly has a stench of death about it, i think its largely to do with the idea that we are seen to be chasing the anti amyloid hypothesis in alzheimers, an aproach that has had billions wasted in clinical trials by much larger companies to date. The company needs to get out an alternate and very positive message that highlights the difference in approach and the success so far. It would be nice to capture the justifyably positive vibe that surrounds Neu at the moment
Ann: FDA End-of Phase 2 Status Update, page-101
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $15.96M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.3¢ | 0.3¢ | $4.579K | 1.526M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 749591 | 0.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.4¢ | 133062022 | 26 |
View Market Depth
| Last trade - 14.03pm 13/09/2024 (20 minute delay) ? |
| ATH (ASX) Chart |